NASDAQ:TBPH | Cash Flow Statement | Theravance Biopharma, Inc.

Complete source-backed cash-flow history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$5.9M
2026-03-31-$4.93M$73.28M$52.59M-$5.58M
2025-12-31$61.02M-$6.06M$588,000.00-$1.49M
2025-09-30$3.62M
2025-06-30$54.84M
2025-03-31-$13.58M$43.04M$30.63M-$854,000.00
2024-12-31-$15.53M-$902,000.00$15.69M$0.00-$365,000.00
2024-09-30-$12.7M
2024-06-30-$16.53M
2024-03-31-$11.66M-$1.02M$17.03M$445,000.00-$1.72M
2023-12-31-$8.51M-$854,000.00-$677,000.00$30.26M-$30.61M
2023-09-30-$8.95M
2023-06-30-$15.65M
2023-03-31-$22.09M-$11.22M-$43.05M$55.35M-$56.24M
2022-12-31-$10.36M-$124.06M$39.16M$34.79M-$35.47M
2022-09-30$916.63M
2022-06-30-$8.19M
2022-03-31-$25.95M-$26.07M$31.92M-$1.45M
2021-12-31-$32.03M-$42.43M$10.82M$149,000.00
2021-09-30-$35.31M
2021-06-30-$52.41M
2021-03-31-$79.68M-$69.87M$113.7M-$11.29M
2020-12-31-$58.43M-$64.93M$52.37M$743,000.00
2020-09-30-$73.64M
2020-06-30-$62.89M
2020-03-31-$83.05M-$55.1M$68.4M$261.43M
2019-12-31-$65.61M-$64.35M$14.06M-$1.54M
2019-09-30-$58.43M
2019-06-30-$39.84M
2019-03-31-$72.58M$1.32M-$81.19M-$72.16M-$1.43M
2018-12-31-$50.19M$858,000.00-$52.18M$99.39M$229.6M
2018-09-30-$59.43M
2018-06-30-$40.82M
2018-03-31-$65.09M$1.01M$49.83M-$11.29M-$1.68M
2017-12-31-$86.92M$1.02M-$44.2M$41.25M$631,000.00
2017-09-30-$66.88M
2017-06-30-$66.29M
2017-03-31-$65.32M$1.08M-$50.03M-$123.52M-$1.22M
2016-12-31-$67.33M$1.18M-$28.11M-$46.21M$332.46M
2016-09-30-$33.96M
2016-06-30-$47.23M
2016-03-31-$42.15M$699,000.00-$26.31M$684,000.00
2015-12-31-$44.83M$697,000.00-$33.75M$606,000.00
2015-09-30-$47.31M
2015-06-30-$47.6M
2015-03-31-$42.47M$825,000.00-$56.51M$657,000.00
2014-12-31-$64.31M$781,000.00-$42.54M$765,000.00
2014-09-30-$54.5M
2014-06-30-$58.22M
2014-03-31-$60.02M$732,000.00-$44.8M$1.62M
2013-12-31-$44.08M$694,000.00-$35.19M$1.07M
2013-09-30-$41.08M
2013-06-30-$38.95M
2013-03-31-$32.17M$703,000.00-$28.49M$740,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$105.9M$238.54M-$105.28M-$3.25M
2024-12-31-$56.42M-$11.54M$12.28M$445,000.00-$2.5M
2023-12-31-$55.19M-$27M-$32.7M$197.05M-$198.93M
2022-12-31$872.13M-$186.99M$1.15B$128.83M-$758.81M
2021-12-31-$199.43M-$207.86M$124.49M$91.86M
2020-12-31-$278.02M-$250.4M$10.72M$263.09M
2019-12-31-$236.46M-$238.2M-$83.05M$1.29M
2018-12-31-$215.52M$3.17M-$112.87M$176.71M$225.2M
2017-12-31-$285.41M$4.03M-$201.05M-$56.33M$1.66M
2016-12-31-$190.67M$3.12M-$98.99M$2.14M-$148.24M$479.23M
2015-12-31-$182.22M$2.99M-$168.86M$2.65M$111.04M$81.31M
2014-12-31-$237.04M$3.27M-$175.16M$3.11M
2013-12-31-$156.28M$2.65M-$120.96M$2.73M
2012-12-31-$9.58M$3.25M-$119.11M$2.59M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.